WELLINGTON MANAGEMENT GROUP LLP

Position in GLUE — Monte Rosa Therapeutics, Inc.

CIK 902219 Boston, MA

Position in GLUE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,019,732

+$2,901,105 QoQ

Shares Held

207,427

+61.1% QoQ

Ownership

0.243%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#52

of 193 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 0% Shared 72% None 28%

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. GLUE ranks #90 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,247,658	$1,613,209,155
2	ARGX	Argenx SE	930,548	$863,334,513
3	REGN	Regeneron Pharmaceuticals, Inc.	1,270,087	$791,950,042
4	RVMD	Revolution Medicines, Inc.	3,843,415	$719,794,757
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,110,407	$635,295,816
6	IONS	Ionis Pharmaceuticals Inc	7,651,415	$606,680,693
7	CYTK	Cytokinetics Inc	6,931,770	$590,517,483
8	MDGL	Madrigal Pharmaceuticals, Inc.	825,714	$443,367,129

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,019,732	207,427	+61.1%	Shares	Defined	2026-08-14
2026-03-31	$2,118,627	128,792	-13.0%	Shares	Defined	2026-05-15
2025-12-31	$2,321,532	148,057	-6.6%	Shares	Defined	2026-02-17
2025-09-30	$1,174,662	158,524	-29.5%	Shares	Defined	2025-11-14
2025-06-30	$1,013,928	224,818	+19.8%	Shares	Defined	2025-08-14
2025-03-31	$871,071	187,731	-15.3%	Shares	Defined	2025-05-13
2024-12-31	$1,538,881	221,741	+2.2%	Shares	Defined	2025-02-12
2024-09-30	$1,150,104	217,001	+30.2%	Shares	Defined	2024-11-14
2024-06-30	$623,349	166,671	+38.1%	Shares	Defined	2024-08-14
2024-03-31	$850,561	120,647	+1212.5%	Shares	Defined	2024-05-15
2021-06-30	$208,658	9,192	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.